Form 4 for INSM INSMED Inc

Accepted 2021-07-09 00:00:00 ET · period of report 2021-07-08 · accession 0001140361-21-023940 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-07-09	2021-07-08	INSM	Smith Michael Alexander	GC, Senior VP	A - Grant	—	+6,722	29.2K	+30%	—
D	2021-07-09	2021-07-08	INSM	Smith Michael Alexander	GC, Senior VP	A - Grant	$0.00	+32.5K	32.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-07-08	A	A	6,722	—	29,228	D	—	—	(F1) Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. (F2) Each Restricted Stock Unit was received as a grant on July 8, 2021, for no consideration.
2	Derivative	Stock Option (right to buy)	2021-07-08	A	A	32,550	$0.00	32,550	D	$27.89 · — to 2031-07-08	32,550 Common Stock	(F3) In connection with the appointment of Mr. Smith as the Company's General Counsel, Senior Vice President, the Company granted Mr. Smith an option to purchase a total of 32,550 shares of the Company's common stock under the Company's 2019 Incentive Plan. The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Mr. Smith's continued employment with the Company on each vesting date.